Irican
Brand Name: Irican
Generic Name: Irinotecan hydrochloride
Active
Registration Number
DR-XY48013
Dosage Form
Solution for IV Infusion
Issuance Date
May 12, 2022
Expiry Date
May 12, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength20 mg/mL
PackagingType I amber glass vial with bromobutyl rubber stopper and polypropylene aluminum flip off seal (Box of 1 vial x 2 mL; Box of 1 vial x 5 mL in 7 mL-capacity)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Irinotecan hydrochlorideActive
Monograph: Irinotecan